TY - JOUR
T1 - Heavy water labeling method for measuring the effect of genistein on mammary gland carcinogenesis
AU - Kim, Hyeon A.
AU - Jeong, Kyu Shik
AU - Park, Dae Hun
AU - Lee, Jeong Ae
AU - Jeong, Won Il
AU - Kim, Yoo Kyeong
PY - 2007/7
Y1 - 2007/7
N2 - Heavy water labeling method was applied to measure the effect of genistein on mammary gland carcinogenesis by incoporating 2H from 2H2O into the deoxyribose (dR) moiety of purine deoxyribonucleotides in dividing cells. In the present study, we followed the study design of Lamartiniere group to evaluate the efficacy of 2H2O labeling on the measurement of mammary gland carconogenesis. Female Sprague-Dawley rats were fed estrogen-free AIN-93G diet starting 1 week before breeding and continuing through pregnancy and lactation. Female pups were assigned to the following groups on postnatal day 16 and fed AIN-93G diet: vehicle (dimethylsulfoxide) (DMSO), genistein, and estradiol benzoate (EB). On postnatal days 16, 18, and 20, female pups were injected subcutaneously with 500 μg genistein/g body wt, 500 ng EB/g body wt, or an equivalent volume of the vehicle. At day 50 postpartum, half of each group were gavaged with 60 mg dimethylbenz[a]anthracene (DMBA) in perila oil. After 1 week of DMBA treatment, all animals were labeled with 2H2O by administration of 4% 2H2O in drinking water after single intraperitonial bolus injection with 99.9% 2H2O until sacrifice on postnatal day 81. The time-dependent weight gains were observed in all groups throughout the experimental period. The enrichment of body 2H2O was attained at 1.84-2.47% through oral administration of 2H2O. Mammary epithelial cell proliferation was measured by enrichment (EM1) of dA from rats. DMBA-treated groups showed higher fractional synthesis than DMBA non-treated groups. The group exposed only to genistein showed significantly lower EM1 (1.46 ± 0.87%) than those of control groups, i.e., the DMBA non-treated group (2.28 ± 0.29%) and the DMBA-treated group (2.32 ± 0.28%). Bromodeoxyuridine (BrdU) immunostaining of mammary tissue revealed that genistein reduced proliferation of the mammary epithelial, and the number of cells stained positive for BrdU both in DMBA-treated groups and DMBA non-treated groups. H&E staining of mammary epithelium also showed that the exposure to genistein decreased proliferation of the mammary epithelium. The epithelium in the rats treated with DMBA showed mostly multiple cell layers, in contrast to the mostly double layer shown in the DMBA non-treated rats. The exposure to genistein in the prepubertal period inhibited mammary epithelial cell proliferation. In conclusion, the 2H2O labeling results were in good agreement with the results of BrdU incorporation and histomorphometry, which demonstrates that 2H2O labeling can be used as a tool to measure carcinogenesis.
AB - Heavy water labeling method was applied to measure the effect of genistein on mammary gland carcinogenesis by incoporating 2H from 2H2O into the deoxyribose (dR) moiety of purine deoxyribonucleotides in dividing cells. In the present study, we followed the study design of Lamartiniere group to evaluate the efficacy of 2H2O labeling on the measurement of mammary gland carconogenesis. Female Sprague-Dawley rats were fed estrogen-free AIN-93G diet starting 1 week before breeding and continuing through pregnancy and lactation. Female pups were assigned to the following groups on postnatal day 16 and fed AIN-93G diet: vehicle (dimethylsulfoxide) (DMSO), genistein, and estradiol benzoate (EB). On postnatal days 16, 18, and 20, female pups were injected subcutaneously with 500 μg genistein/g body wt, 500 ng EB/g body wt, or an equivalent volume of the vehicle. At day 50 postpartum, half of each group were gavaged with 60 mg dimethylbenz[a]anthracene (DMBA) in perila oil. After 1 week of DMBA treatment, all animals were labeled with 2H2O by administration of 4% 2H2O in drinking water after single intraperitonial bolus injection with 99.9% 2H2O until sacrifice on postnatal day 81. The time-dependent weight gains were observed in all groups throughout the experimental period. The enrichment of body 2H2O was attained at 1.84-2.47% through oral administration of 2H2O. Mammary epithelial cell proliferation was measured by enrichment (EM1) of dA from rats. DMBA-treated groups showed higher fractional synthesis than DMBA non-treated groups. The group exposed only to genistein showed significantly lower EM1 (1.46 ± 0.87%) than those of control groups, i.e., the DMBA non-treated group (2.28 ± 0.29%) and the DMBA-treated group (2.32 ± 0.28%). Bromodeoxyuridine (BrdU) immunostaining of mammary tissue revealed that genistein reduced proliferation of the mammary epithelial, and the number of cells stained positive for BrdU both in DMBA-treated groups and DMBA non-treated groups. H&E staining of mammary epithelium also showed that the exposure to genistein decreased proliferation of the mammary epithelium. The epithelium in the rats treated with DMBA showed mostly multiple cell layers, in contrast to the mostly double layer shown in the DMBA non-treated rats. The exposure to genistein in the prepubertal period inhibited mammary epithelial cell proliferation. In conclusion, the 2H2O labeling results were in good agreement with the results of BrdU incorporation and histomorphometry, which demonstrates that 2H2O labeling can be used as a tool to measure carcinogenesis.
KW - BrdU
KW - Cell proliferation
KW - Genistein
KW - Heavy water (HO)
KW - Mammary gland carcinogenesis
UR - http://www.scopus.com/inward/record.url?scp=34250167943&partnerID=8YFLogxK
U2 - 10.1007/s11010-007-9412-y
DO - 10.1007/s11010-007-9412-y
M3 - Article
C2 - 17318409
AN - SCOPUS:34250167943
SN - 0300-8177
VL - 301
SP - 201
EP - 208
JO - Molecular and Cellular Biochemistry
JF - Molecular and Cellular Biochemistry
IS - 1-2
ER -